HRMY – Harmony Biosciences Holdings, Inc.

Harmony Biosciences Holdings, I

HRMY

$28.46

Name : Harmony Biosciences Holdings, I

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $1,633,225,472.00

EPSttm : 2.51

Harmony Biosciences Holdings, I

$28.46

1.86%

$0.52

Float Short %

8.02

Margin Of Safety %

Put/Call OI Ratio

0.27

EPS Next Q Diff

0.32

EPS Last/This Y

1.96

EPS This/Next Y

0.59

Price

28.46

Target Price

51.89

Analyst Recom

1.33

Performance Q

-26.15

Relative Volume

0.64

Beta

0.86

Ticker: HRMY

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-03-21	HRMY	35.27	0.41	0.02	3227
2025-03-24	HRMY	34.22	0.45	0.22	2721
2025-03-25	HRMY	33.02	0.47	5.00	2767
2025-03-26	HRMY	33.2	0.47	0.00	2777
2025-03-27	HRMY	33.34	0.47	0.07	2777
2025-03-28	HRMY	33.17	0.47	14.00	2789
2025-03-31	HRMY	33.18	0.51	6.67	2849
2025-04-01	HRMY	32.13	0.51	0.38	2869
2025-04-02	HRMY	32.52	0.52	0.14	2842
2025-04-03	HRMY	30.96	0.54	0.04	2801
2025-04-04	HRMY	29.25	0.55	0.88	2794
2025-04-07	HRMY	28.39	0.55	0.38	2792
2025-04-08	HRMY	28.16	0.54	0.40	2782
2025-04-09	HRMY	29.06	0.56	0.15	2712
2025-04-10	HRMY	29.01	0.59	0.45	2566
2025-04-11	HRMY	29.18	0.30	0.40	2053
2025-04-14	HRMY	29.55	0.30	10.50	2056
2025-04-15	HRMY	28.71	0.27	0.02	2019
2025-04-16	HRMY	27.93	0.25	3.81	2154
2025-04-17	HRMY	28.5	0.27	0.30	2178
2025-04-18	HRMY	28.46	0.27	0.27	2178
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-03-21	HRMY	35.27	23.5	96.8	4.52
2025-03-24	HRMY	34.24	23.5	82.7	4.52
2025-03-25	HRMY	32.99	23.5	80.1	4.52
2025-03-26	HRMY	33.21	23.5	95.3	4.52
2025-03-27	HRMY	33.35	23.5	94.5	4.52
2025-03-28	HRMY	33.19	23.5	91.3	4.52
2025-03-31	HRMY	33.17	23.5	92.8	4.52
2025-04-01	HRMY	32.42	23.5	84.8	4.52
2025-04-02	HRMY	32.53	23.5	94.3	4.52
2025-04-03	HRMY	30.95	23.5	75.7	4.52
2025-04-04	HRMY	29.25	23.5	72.9	4.52
2025-04-07	HRMY	28.37	23.5	82.1	4.52
2025-04-08	HRMY	28.13	23.5	90.6	4.52
2025-04-09	HRMY	29.04	23.5	105.0	4.52
2025-04-10	HRMY	29.02	23.5	92.4	4.52
2025-04-11	HRMY	29.20	23.5	95.6	4.52
2025-04-14	HRMY	29.53	23.5	97.4	4.52
2025-04-15	HRMY	28.75	23.5	83.4	4.52
2025-04-16	HRMY	27.95	23.5	82.8	4.52
2025-04-17	HRMY	28.46	23.5	99.9	4.52
2025-04-18	HRMY	28.46	23.5	93.1	4.52
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-03-21	HRMY	-40.33	6.32	8.96
2025-03-24	HRMY	-40.33	6.05	8.96
2025-03-25	HRMY	-40.33	6.05	8.96
2025-03-26	HRMY	-40.33	6.05	9.46
2025-03-27	HRMY	-40.33	6.05	9.46
2025-03-28	HRMY	-40.33	6.05	9.46
2025-03-31	HRMY	-40.33	6.04	9.46
2025-04-01	HRMY	-40.24	6.04	9.46
2025-04-02	HRMY	-40.24	6.04	9.46
2025-04-03	HRMY	-40.25	6.04	9.46
2025-04-04	HRMY	-40.25	6.04	9.46
2025-04-07	HRMY	-40.24	6.06	9.46
2025-04-08	HRMY	-40.30	6.06	9.46
2025-04-09	HRMY	-40.29	6.06	9.46
2025-04-10	HRMY	-40.29	6.06	8.02
2025-04-11	HRMY	-40.29	6.06	8.02
2025-04-14	HRMY	-40.29	6.04	8.02
2025-04-15	HRMY	-40.29	6.04	8.02
2025-04-16	HRMY	-40.29	6.04	8.02
2025-04-17	HRMY	-40.29	6.04	8.02
2025-04-18	HRMY	-40.29	6.04	8.02
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

0.85

Avg. EPS Est. Current Quarter

1.09

Avg. EPS Est. Next Quarter

1.17

Insider Transactions

-40.29

Institutional Transactions

6.04

Beta

0.86

Average Sales Estimate Current Quarter

184

Average Sales Estimate Next Quarter

205

Fair Value

46.79

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

54.2

Max Drawdown 5-Year %

Target Price

51.89

P/E

11.34

Forward P/E

7.03

PEG

0.41

P/S

2.29

P/B

2.47

P/Free Cash Flow

7.47

EPS

2.51

Average EPS Est. Cur. Y

4.52

EPS Next Y. (Est.)

5.11

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

20.36

Relative Volume

0.64

Return on Equity vs Sector %

2.1

Return on Equity vs Industry %

15.5

EPS 1 7Days Diff

0.7

EPS 1 30Days Diff

0.22

EBIT Estimation

93.1

Harmony Biosciences Holdings, I

Sector: Healthcare

Industry: Biotechnology

Employees: 268

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also develops Pitolisant that is in Phase 3 clinical trial for the treatment of Prader-Willi Syndrome (PWS); in Phase 2 clinical trial to treat Myotonic Dystrophy (DM1); and is in Phase 1 clinical trials for the treatment of Pitolisant Gastro-Resistant (GR) and High-Dose (HD). In addition, the company's products under development include BP1.15205, an orexin 2 receptor agonist for the treatment of narcolepsy and other potential indications; and HBS-102, a melanin-concentrating hormone receptor type 1 (MCHR1) antagonist. Further, it develops ZYN-002 that is in a Phase 3 registrational trial for the treatment of Fragile X Syndrome (FXS), rare genetic disorder that causes inherited intellectual disability and autism spectrum disorder; and 22q Deletion Syndrome, a disorder caused by a small missing piece on the long arm of the 22nd chromosome. Additionally, the company is developing EPX-100 (clemizole hydrochloride), a serotonin (5HT-2) receptor agonist to treat dravet syndrome and lenox-gastaut syndrome; and EPX-200 (liquid formulation of lorcaserin), a selective 5HT-2C agonist to treat developmental and epileptic encephalopathies (DEE). The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.

stock quote shares HRMY – Harmony Biosciences Holdings, Inc. Stock Price stock today

news today HRMY – Harmony Biosciences Holdings, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch HRMY – Harmony Biosciences Holdings, Inc. yahoo finance google finance

stock history HRMY – Harmony Biosciences Holdings, Inc. invest stock market

stock prices HRMY premarket after hours

ticker HRMY fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

HRMY – Harmony Biosciences Holdings, Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: HRMY

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y